Drug intelligence / Profile preview

1-guanidino-4-(N-nitro-benzoylamino-L-leucyl-L-prolylamino)butane

Development stage
Unknown
Modality
Small Molecules, Peptides
01

Overview

1-Guanidino-4-(N-nitro-benzoylamino-L-leucyl-L-prolylamino)butane is a synthetic small molecule dipeptide derivative, structurally related to amino acids leucine and proline, with a guanidinium group and a nitrobenzoyl moiety. It is classified as an experimental compound and has not been approved for clinical use. The compound has been studied in the context of protein interactions, notably as a ligand in structural studies involving prothrombin/thrombin, suggesting it may act as an inhibitor or modulator of serine proteases involved in blood coagulation. However, no specific mechanism of action or therapeutic indication has been established for this molecule[1][3][7].

Other names
(2S)-N-{4-[(diaminomethylidene)amino]butyl}-1-[(2S)-4-methyl-2-[(4-nitrophenyl)formamido]pentanoyl]pyrrolidine-2-carboxamideN-(4-nitrobenzoyl)-L-leucyl-N-{4-[(diaminomethylene)amino]butyl}-L-prolinamideN-(4-NITROBENZOYL)-L-leucyl-N-(4-{[amino(imino)methyl]amino}butyl)-L-prolinamide

Beyond the preview

Go deeper on 1-guanidino-4-(N-nitro-benzoylamino-L-leucyl-L-prolylamino)butane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-guanidino-4-(N-nitro-benzoylamino-L-leucyl-L-prolylamino)butane.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call